Author/Authors :
Weihua، نويسنده , , Zhang and Tsan، نويسنده , , Rachel and Huang، نويسنده , , Wei-Chien and Wu، نويسنده , , Qiuyu and Chiu، نويسنده , , Chao-Hua and Fidler، نويسنده , , Isaiah J. and Hung، نويسنده , , Mien-Chie، نويسنده ,
Abstract :
Summary
sion of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase associated with cell proliferation and survival, is overactive in many tumors of epithelial origin. Blockade of the kinase activity of EGFR has been used for cancer therapy; however, by itself, it does not seem to reach maximum therapeutic efficacy. We report here that in human cancer cells, the function of kinase-independent EGFR is to prevent autophagic cell death by maintaining intracellular glucose level through interaction and stabilization of the sodium/glucose cotransporter 1 (SGLT1).